These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1665 related articles for article (PubMed ID: 33712273)

  • 1. A possible association between hydatidiform mole and the COVID-19 pandemic: A retrospective cohort study.
    Aiob A; Naskovica K; Sharon A; Bornstein J
    Gynecol Oncol; 2021 May; 161(2):454-457. PubMed ID: 33712273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and diagnosis of early hydatidiform mole].
    Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydatidiform mole in Turkey: results from six centers.
    Oge T; Ozalp SS; Güngör T; Yildirim Y; Sanci M; Dogan A; Ertas IE; Yetimalar H; Dilek S; Celik C
    J Reprod Med; 2012; 57(5-6):259-61. PubMed ID: 22696823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
    Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
    Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
    Stone M; Bagshawe KD
    Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
    Joneborg U; Folkvaljon Y; Papadogiannakis N; Lambe M; Marions L
    Acta Oncol; 2018 Aug; 57(8):1094-1099. PubMed ID: 29451409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of hydatidiform mole and choriocarcinoma.
    Bracken MB; Brinton LA; Hayashi K
    Epidemiol Rev; 1984; 6():52-75. PubMed ID: 6386504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical features of complete and partial hydatidiform mole in Sweden.
    Joneborg U; Marions L
    J Reprod Med; 2014; 59(1-2):51-5. PubMed ID: 24597287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational trophoblastic disease within an elective abortion population.
    Cohen BA; Burkman RT; Rosenshein NB; Atienza MF; King TM; Parmley TH
    Am J Obstet Gynecol; 1979 Oct; 135(4):452-4. PubMed ID: 484643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pre-evacuation ultrasound examination in histologically confirmed hydatidiform mole in missed abortion.
    Tang Y; Zhu C; Zhu C; Liang F; Lee A; Yao X; Chen Q
    BMC Womens Health; 2020 Sep; 20(1):196. PubMed ID: 32912152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P57
    Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
    Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in diagnostic sensitivity, incidence and presentation of complete and partial hydatidiform mole over the years.
    Aiob A; Naskovica K; Amdur Zilberfarb I; Sharon A; Bornstein J; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():136-141. PubMed ID: 35640442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiologic features of hydatidiform mole in the Netherlands.
    Franke HR; Risse EK; Kenemans P; Vooijs GP; Stolk JG
    Obstet Gynecol; 1983 Nov; 62(5):613-6. PubMed ID: 6621952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydatidiform mole as seen in a university teaching hospital: a 10-year review.
    Audu BM; Takai IU; Chama CM; Bukar M; Kyari O
    J Obstet Gynaecol; 2009 May; 29(4):322-5. PubMed ID: 19835501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Reappraisal of the Incidence of Placental Hydatidiform Mole Using Selective Molecular Genotyping.
    Colgan TJ; Chang MC; Nanji S; Kolomietz E
    Int J Gynecol Cancer; 2016 Sep; 26(7):1345-50. PubMed ID: 27258730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of partial molar pregnancy.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Obstet Gynecol; 1985 Nov; 66(5):677-81. PubMed ID: 2414703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydatidiform molar pregnancy in Malaysian women: a histopathological study from the University Hospital, Kuala Lumpur.
    Cheah PL; Looi LM; Sivanesaratnam V
    Malays J Pathol; 1993 Jun; 15(1):59-63. PubMed ID: 8277792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydatidiform mole and subsequent pregnancy outcome: a population-based cohort study.
    Joneborg U; Eloranta S; Johansson AL; Marions L; Weibull CE; Lambe M
    Am J Obstet Gynecol; 2014 Dec; 211(6):681.e1-7. PubMed ID: 24949537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.